Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (191-200 of 260) with videos related to

Pageof 26
Sort By:
Biochemical Pharmacology|March 23, 1999
Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cellsK V Ferry, D Fink, S W Johnson, et al.
Genes, Chromosomes & Cancer|April 1, 1997
Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cellsV M Wasenius, A Jekunen, O Monni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Improved targeting of platinum chemotherapeutics. the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour modelsX Lin, Q Zhang, J R Rice, et al.
Journal of the National Cancer Institute|August 1, 1980
Thymidine as a chemotherapeutic agent: pharmacologic, cytokinetic, and biochemical studies in a patient with T-cell acute lymphocytic leukemiaS B Howell, B Chu, J Mendelsohn, et al.
Obstetrics and Gynecology|May 1, 1993
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancerS C Plaxe, P S Braly, J L Freddo, et al.
Gynecologic Oncology|June 1, 1993
High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensityA Bonetti, S B Howell, E McClay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Dose intensification of cisplatin chemotherapy through biweekly administrationS Kim, S B Howell, E McClay, et al.
Biochemical Pharmacology|May 25, 1993
Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitroA P Jekunen, D R Shalinsky, D K Hom, et al.
The Journal of Clinical Investigation|July 1, 1993
In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubulesR D Christen, A P Jekunen, J A Jones, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 1998
Prediction-based threading of the hMSH2 DNA mismatch repair proteinM M de las Alas, R A de Bruin, L Ten Eyck, et al.
Pageof 26

Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
Biochemical Pharmacology|March 23, 1999
Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cellsK V Ferry, D Fink, S W Johnson, et al.
Genes, Chromosomes & Cancer|April 1, 1997
Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cellsV M Wasenius, A Jekunen, O Monni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Improved targeting of platinum chemotherapeutics. the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour modelsX Lin, Q Zhang, J R Rice, et al.
Journal of the National Cancer Institute|August 1, 1980
Thymidine as a chemotherapeutic agent: pharmacologic, cytokinetic, and biochemical studies in a patient with T-cell acute lymphocytic leukemiaS B Howell, B Chu, J Mendelsohn, et al.
Obstetrics and Gynecology|May 1, 1993
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancerS C Plaxe, P S Braly, J L Freddo, et al.
Gynecologic Oncology|June 1, 1993
High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensityA Bonetti, S B Howell, E McClay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Dose intensification of cisplatin chemotherapy through biweekly administrationS Kim, S B Howell, E McClay, et al.
Biochemical Pharmacology|May 25, 1993
Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitroA P Jekunen, D R Shalinsky, D K Hom, et al.
The Journal of Clinical Investigation|July 1, 1993
In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubulesR D Christen, A P Jekunen, J A Jones, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 1998
Prediction-based threading of the hMSH2 DNA mismatch repair proteinM M de las Alas, R A de Bruin, L Ten Eyck, et al.
Pageof 26